Cash Flow - Janux Therapeutics, Inc. (JANX)
$(Billion, Million)| Dec-25 | Dec-24 | Dec-23 | Dec-22 | Dec-21 | Dec-20 | Dec-19 | |
|---|---|---|---|---|---|---|---|
| Operating cash flow | -82.24 | -43.81 | -50.58 | -42.92 | -16.98 | -4.37 | -3.83 |
| Cash flow from investing | -300.98 | -258.02 | -41.19 | 58.27 | -340.96 | -340.96 | -340.96 |
| Cash flow from financing | 4.95 | 713.24 | 59.55 | 0.50 | 386.52 | 11.52 | 4.00 |
| Change in cash | -378.27 | 411.40 | -32.22 | 15.84 | 28.59 | -333.81 | -340.79 |
Show Quarterly Cash Flow
Cash Flow - Janux Therapeutics, Inc. (JANX)
$(Billion, Million)| Mar-26 | Dec-25 | Sep-25 | Jun-25 | Mar-25 | Dec-24 | Sep-24 | Jun-24 | Mar-24 | Dec-23 | Sep-23 | Jun-23 | Mar-23 | Dec-22 | Sep-22 | Jun-22 | Mar-22 | Dec-21 | Sep-21 | Jun-21 | Mar-21 | Dec-20 | Sep-20 | Jun-20 | Mar-20 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating cash flow | -12.34 | -28.54 | -12.86 | -23.81 | -17.02 | -16.73 | -2.23 | -10.02 | -14.84 | -9.90 | -11.71 | -15.05 | -13.91 | -11.91 | -13.41 | -6.07 | -11.52 | -10.48 | -5.85 | -6.20 | 5.56 | -1.63 | -1.08 | -0.78 | -0.88 |
| Cash flow from investing | 8.29 | 29.54 | 8.31 | 1.56 | -340.39 | 33.93 | 12.67 | -190.89 | -113.74 | 11.12 | -61.45 | 17.87 | -8.74 | -1.60 | 19.76 | 9.04 | 31.07 | 7.33 | -205.54 | -142.60 | -0.15 | -0.15 | -0.15 | -0.15 | |
| Cash flow from financing | 3.55 | 2.94 | 0.49 | 0.95 | 0.55 | 386.65 | 1.65 | 2.77 | 322.17 | 0.83 | 56.61 | 0.53 | 1.58 | 0.19 | 0.19 | 0.31 | 0.00 | 0.16 | -0.84 | 329.66 | 57.55 | 4.55 | -0.03 | 5.50 | 1.50 |
| Change in cash | -0.51 | 3.95 | -4.06 | -21.30 | -356.86 | 403.85 | 12.09 | -198.14 | 193.60 | 2.05 | -16.55 | 3.35 | -21.07 | -13.33 | 6.54 | 3.27 | 19.55 | -2.99 | -212.24 | 180.86 | 62.96 | 2.92 | -1.27 | 4.57 | 0.48 |